Stemrx Bioscience Solutions Private Limited

Stemrx Bioscience Solutions Private Limited - life sciences in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U93030MH2014PTC253238 Incorporated 13 February 2014 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company life sciences MSME · Small
Revenue · FY 2025
₹13.63 Cr
▼ 17% YoY
Net profit · FY 2025
₹50.83 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹2.03 Cr
EBITDA margin 14.9%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.28 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
6
Provident fund records

About Stemrx Bioscience Solutions Private Limited

Data last updated:

Stemrx Bioscience Solutions Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U93030MH2014PTC253238. Its GSTIN is 27AAUCS3062R1ZD (Maharashtra).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.28 Lakh. It is led by directors including Neetin Shivajirao Desai and Pradeep Venkatrao Mahajan.

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708.

As per the financials filed for FY 2025, the company reported a revenue of ₹13.63 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹50.83 Lakh (net margin 3.7%) and EBITDA of ₹2.03 Cr (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 10% over five years.

The company has about 6 employees on its provident fund (EPFO) records.

The company is associated with 4 brands: Stemrx Biosciences, OrbisX, Stemrx Bioscience and Vrozart Health. As per MCA filings, the company has open charges of ₹20 Lakh on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.

Stemrx Bioscience Solutions Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0072618). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stemrx.in.

Company details

CIN U93030MH2014PTC253238
Registration Number 253238
Incorporation Date 13 February 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0072618

Recognitions & Rankings of Stemrx Bioscience Solutions

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-33-0072618

Contact details

Stemrx Bioscience Solutions Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is stemrx.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    First Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Stemrx Bioscience Solutions Private Limited, buy the company report.

Comprehensive company report
Stemrx Bioscience Solutions Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Stemrx Bioscience Solutions operates multiple associated brands including Stemrx Biosciences, OrbisX, and Stemrx Bioscience. Each brand links to its own profile.

BrandDescriptionWebsite
StemRx Biosciences develops regenerative medicine and sells herbal supplements online.stemrxbiosciences.in
CRM software for automotive detailers and tinters to manage bookings, inventory, and communications.orbisx.com
Regenerative medicine and nutraceutical supplements in India.stemrxbiosciences.com
Provider of medical tourism servicesvrozarthealth.com

Business activity

The main business activity of Stemrx Bioscience Solutions is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Stemrx Bioscience Solutions Private Limited, buy the company report.

Financials of Stemrx Bioscience Solutions Private Limited

FY 2025 filings available

Stemrx Bioscience Solutions Private Limited reported revenue of ₹13.63 Cr (down 17% YoY) for FY 2025.

Revenue · FY 2025
₹13.63 Cr ▼ 17%
Net profit · FY 2025
₹50.83 Lakh margin 3.7%
EBITDA · FY 2025
₹2.03 Cr margin 14.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 37%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 24%
5 years · compounded
▲ 12%

Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.03 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹50.83 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14.9%
Net Profit Margin3.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Stemrx Bioscience Solutions Private Limited, buy the company report.

Board of directors of Stemrx Bioscience Solutions Private Limited

Stemrx Bioscience Solutions has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Neetin Shivajirao DesaiDirector13 Feb 201412 Years 9 MonthsCurrent
Pradeep Venkatrao MahajanDirector13 Feb 201412 Years 9 MonthsCurrent
Vipula Pradeep MahajanDirector13 Feb 201412 Years 9 MonthsCurrent

Auditor

Stemrx Bioscience Solutions Private Limited is audited by MANOJ H JAISWAL for the financial year 2022.

Auditor firmFinancial yearFirm registration number
MANOJ H JAISWALFY 2022150561

Shareholding

The shareholding of Stemrx Bioscience Solutions Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Stemrx Bioscience Solutions Private Limited, buy the company report.

Charges & borrowings

Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Idbi Bank Limited₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Aug 2015100029438Idbi Bank Limited₹20 LakhOpen

Total charge records: 1 View all charges

Deals & funding

Stemrx Bioscience Solutions Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.

Total deals
1
Funding round
1
Disclosed funding
₹2 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Aug 2020Funding round₹2 CrInvestors: Birthstone Capital

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Stemrx Bioscience Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Stemrx Bioscience Solutions Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
6
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-276
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19

To see the full employee and EPFO history of Stemrx Bioscience Solutions Private Limited, buy the company report.

GST

Stemrx Bioscience Solutions has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAUCS3062R1ZDMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Stemrx Bioscience Solutions Private Limited, buy the company report.

Recent activity

Stemrx Bioscience Solutions Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Aken Jatin Sanghavi ceased to be Additional Director on 18 Nov 2022.

AGM
Stemrx Bioscience Solutions Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Stemrx Bioscience Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Aken Jatin Sanghavi ceased to be Additional Director.
Ceased
Siddhant Pradeep Mahajan ceased to be Director.
Ceased
Vijay Gopal Pandhare ceased to be Director.
Charges
A charge with Idbi Bank Limited amounted to Rs. 20.00 Lakh with Charge ID 100029438 was registered on 26 Aug 2015.
Appointed
Neetin Shivajirao Desai was appointed as Director.
Appointed
Pradeep Venkatrao Mahajan was appointed as Director.
Appointed
Vipula Pradeep Mahajan was appointed as Director.
Incorporation
13 Feb 2014
Stemrx Bioscience Solutions Private Limited was registered on 13 Feb 2014 with Roc Mumbai & aged 12 years 9 months as per MCA records.

Frequently asked questions

Stemrx Bioscience Solutions is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U93030MH2014PTC253238.

Stemrx Bioscience Solutions has 3 current directors:

The latest financial statements of Stemrx Bioscience Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Stemrx Bioscience Solutions is 27AAUCS3062R1ZD, registered in Maharashtra.

The CIN (Corporate Identification Number) of Stemrx Bioscience Solutions is U93030MH2014PTC253238. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stemrx Bioscience Solutions was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

Stemrx Bioscience Solutions has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.

Aken Jatin Sanghavi ceased to be Additional Director on 18 Nov 2022. Siddhant Pradeep Mahajan ceased to be Director on 18 Oct 2021. Vijay Gopal Pandhare ceased to be Director on 03 Sep 2015. Stemrx Bioscience Solutions has 6 board changes on record in total.

Yes, Stemrx Bioscience Solutions is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0072618).

Stemrx Bioscience Solutions can be reached through the website stemrx.in. Its registered office is in Navi Mumbai, Maharashtra, India.